该网站是Informa Plc informa Connect部门的一部分

该网站由Informa Plc拥有的业务或企业运营，所有版权所有于它们。Informa Plc的注册办事处是伦敦SW1P 1WG伦敦豪克斯的录入办公室。在英格兰和威尔士注册。数字3099067。

信息

Browse our events, training, articles and people by topicclose

普遍的部门

A - Z

Browse Topics apps close
search

Biotech，Medtech和数字健康的投资

Discover and invest in the most innovative companies in medtech, digital health, AI, and biotechnology.

文章和视频

显示21个共55篇文章和视频
特色
Biotech Showcase™ 2020

12 VCs who matter in biotech, but you hardly ever read about
Biopharm America™2020

Biotech Startups: How to Succeed in a COVID-19 World

Taking a biotech company from concept, through clinical trials, and ultimately to market requires a perfect storm of good science, a sound investment, and the right management. This ebook is here to guide startups through this journey.
卫生保健

报告：医疗保健后的未来Covid-19

In our latest report learn how healthcare organizations are adapting to succeed post COVID-19, from innovation to product development.
ChinaBio Partnering Forum 2020

采访：在全球生命科学的多样性和合作的重要性金博宝188备用地址

Atlatl创新集群（IC）在张江医药山谷的中心地带。它的创始人兼首席执行官P.C博士。朱先生设计它是中国高潜在的生命科学的推出板。在这次采访中，他讨论了大概的机会提供的机会，也是在生命科学行业合作的重要性。金博宝188备用地址
ChinaBio Partnering Forum 2020

Video Interview - Johnson & Johnson’s approach to external innovation

MD，MD，博士，博士，博士，博士，博士兼全球联队局联恩省外部创新为吕西·埃利斯（Pharma Intelligence）的执行编辑提供了专门的采访，以前ChinaBio®合作论坛数字。金博宝188备用地址
ChinaBio Partnering Forum 2020

采访 - j＆j对生命科学创新，伙伴关系和先进技术的多管途径方法

丹森和约翰逊创新，亚太地区，亚太地区，亚太地区的博士博士，亚太·詹博士@上海博士讨论了对各种疾病领域的初创性，兴趣，合作的重要性以及更多的独家访谈eBD组。
ChinaBio Partnering Forum 2020

REPORT: State of China Life Science - 2020 H1

下载新的ExclusiveChinaBio®报告，深入分析了中国投资和合作活动的2020 H1，以发现推动中国生命科学投资的因素。金博宝188备用地址尽管Covid-19，但仍然了解VC，IPO和金博宝188备用地址合作伙伴的重点是如何反弹，但并购如何持续下滑。
药物开发

China's Challenges and Opportunities in the Wake of COVID-19

Discover how pharma companies in China are collaborating like never before to keep the supply chain from breaking, as well as asking the government to help address a flurry of issues laid bare by the public health crisis.
ChinaBio Partnering Forum 2020

Interview- Roche’s approach to drug discovery, innovation and meeting patients' needs

James Sabry, Global Head of Roche Pharma Partnering, discusses Roche’s approach to discovering scientific breakthroughs, accelerating innovative research, collaborating with stakeholders, and meeting unmet medical needs in China and around the world.
Life Sciences

The biggest breakthroughs in life sciences the last 10 years

CRISPR，CAR-T，免疫疗法，基因组测序，AI - 过去10年的生命科学最大的突破是什么？
Premiumget_app
多元化和包容性

Diversity in the life sciences workplace: Implementing a leading corporate culture for innovation - WHITEPAPER

本文着眼于如何促进种族,性别,geographical, neuro and cognitive diversity in the life sciences to achieve an inclusive culture built for innovation.
Diversity

REPORT: Diversity, Inclusion and Sustainability in the Global Life Sciences Industry 2020

多元化和包容性in Life Sciences 2020: Research analysis of how life sciences professionals around the world view representation of women and minorities in the industry, plus the importance of sustainability.
Life Sciences

Looking to 2030 Report: The Future of the Global Life Sciences and Pharma Industry

This exclusive report looks at predictions for how the global life sciences and pharma industry will change over the coming decade.
Premium
COVID-19

COVID-19 Report: The Response to and Impacts on the Global Life Sciences Industry

Covid-19报告：生命科学行业如何为Covid-19开发疫苗，治疗和测试以及供应链的影响是什么？
生物欧洲春天

Containing Coronavirus Through Innovation and Investment: An Xconomy Special Report

This report contains ideas, innovation, and experience from some of the major players at the forefront of efforts in combatting COVID-19. The exclusive articles were captured from the BIO-Europe Spring® event and are accompanied by some of the most pertinent stories from B2B publications Xconomy and Bioprocess Insider.
生物欧洲春天

A Backstage View Of Roche’s Recent Collaborations

In an exclusive interview, Barbara Lueckel, global head of research technologies at Roche Pharma Partnering, talks about the rationale behind the 2020 deals with Bicycle Therapeutics and Nimble Therapeutics. She gives insight into how deal makers are shifting gears to make deals happen in the challenging environment of the global coronavirus pandemic.
生物欧洲春天

Oncology Needs Combo Therapies & More Data Analysis, Says BIO-Europe Spring Panel

Future improvements in cancer care are most likely to stem from combinations therapies and data-driven prevention efforts, as well as breakthrough drugs. That’s the message life sciences experts shared this week during a webcast on the topic of “oncology’s next decade” recorded for the BIO-Europe Spring partnering conference.
Premium
MedTech

MedTech Report 2020: EU MDR and IVDR Compliance

根据行业内部人士的265次调查回复，下载欧盟MDR和IVDR合规性的Medtech报告2020。
Survey

Life Sciences in 2030 Survey: Complete to win a 2-day conference pass

We are a conducting a huge survey of life sciences professionals around the world on how the industry will look by 2030. Complete it here to get early access to the final report.
药物开发

平台成功使得毒品发现和发展的新方法

Relatively small Enabling Technology Platform companies are changing the future for patients, drug discovery scientists, therapeutic scientists, developers, new therapy approach scientists, plus payers. Sometimes, it is important to remind oneself that biotech is working for the good of the worldwide healthcare industry and not just our local markets.
BIOEuropeSpring

Paris Region to lead the field in personalized medicine and biopharma 3.0

在这里的2015年会议的巨大成功之后，医生巴黎地区令主持2020年版生物欧洲春季。巴黎地区是一个全球枢纽，当涉及到医疗保健创新，以及谈到生物野蛮的第一个欧洲地区。它确实是1,000多个生命科学初创公司，超过1,200个公共和私人研发实验室和12,000名生命科学研究员和欧洲最大的医院网络。

版权所有©2020.金宝搏App下载